| Anti-inflammatory activity of fucoidan extracts in vitro T Ahmad, MS Eapen, M Ishaq, AY Park, SS Karpiniec, DN Stringer, ... Marine Drugs 19 (12), 702, 2021 | 63 | 2021 |
| Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanisms Y Chan, SW Ng, JZX Tan, G Gupta, MM Tambuwala, HA Bakshi, H Dureja, ... Chemico-biological interactions 315, 108911, 2020 | 27 | 2020 |
| Synbiotics as supplemental therapy for the alleviation of chemotherapy-associated symptoms in patients with solid tumours NK Singh, JM Beckett, K Kalpurath, M Ishaq, T Ahmad, RD Eri Nutrients 15 (7), 1759, 2023 | 15 | 2023 |
| Oral Macrocystis pyrifera Fucoidan Administration Exhibits Anti-Inflammatory and Antioxidant Properties and Improves DSS-Induced Colitis in C57BL/6J Mice T Ahmad, M Ishaq, S Karpiniec, A Park, D Stringer, N Singh, V Ratanpaul, ... Pharmaceutics 14 (11), 2383, 2022 | 13 | 2022 |
| Asperuloside enhances taste perception and prevents weight gain in high-fat fed mice M Ishaq, D Tran, Y Wu, K Nowak, BJ Deans, JTZ Xin, HL Loh, WY Ng, ... Frontiers in endocrinology 12, 615446, 2021 | 9 | 2021 |
| Metabolic changes induced by purinergic signaling: role in food intake V Caruso, M Zuccarini, P Di Iorio, I Muhammad, M Ronci Frontiers in pharmacology 12, 655989, 2021 | 7 | 2021 |
| Fucoidan as an inhibitor of pro‐inflammatory cytokines: Potential candidate for treating inflammatory‐related conditions T Ahmad, M Ishaq, M Eapen, N Singh, A Park, S Karpiniec, D Stringer, ... The FASEB Journal 36, 2022 | 2 | 2022 |
| The anti-obesity compound Asperuloside reduces inflammation in the liver and hypothalamus of high-fat-fed mice M Ishaq, D Tran, C Yang, MJ Ng, A Kackanattil, K Tata, BJ Deans, ... Endocrines 3 (4), 641-653, 2022 | | 2022 |
| Asperuloside, a natural compound with potent weight-loss properties: a novel therapeutic purinergic signalling approach for the treatment of obesity I Muhammad, M Zuccarini, M Ronci, V Caruso University Of Tasmania, 2022 | | 2022 |
| Asperuloside reduces food intake and body weight via downregulation of orexigenic hypothalamic signalling in a mouse model of metabolic syndrome. V Caruso, M Ishaq, D Tran, C Yang, S Vicenzi, N Guven, B Deans, ... The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
| Asperuloside reduces food intake and body weight via downregulation of orexigenic hypothalamic signalling in a mouse model of metabolic syndrome JCVC I. muhammad, D. Tran1, C.Yang1, S.Vicenzi, T.ahmad, C. Randall, B ... Australasian Neuroscience Society 39, 2019 | | 2019 |
| Obesity research: Asperuloside induces weight loss plausibly via melanocortin signalling Muhammad ishaq, K Nowak, Duyen Tran, Cameron Randall, Bianca Judith Deans ... Australasian Neuroscience Society 38, 2018 | | 2018 |
Vanni CarusoUniversity of Tasmania在 utas.edu.au 的电子邮件经过验证
